Clinical Trial Update: Neuroendocrine Neoplasms Methylation Based Classifier - The NEMESIs-study

View source ↗

Summary

The NEMESIs-study evaluates a methylation-based classifier for neuroendocrine tumors and is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumors

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Neuroendocrine Tumors | Status: COMPLETED